Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$17.3B
sum of reported positions
Reported positions
354
Changes vs prior quarter
395
84 new · 85 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 396 measured positions in 8 quarters, the typical new or larger position finished −3.9 pts against the S&P 500 and 42% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 985K | $470M | 2.7% | |
| 6.85M | $322M | 1.9% | |
| 959K | $321M | 1.9% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $13.6B | $17.3B |
| Positions | 355 | 354 |
| Biggest line | — | Taiwan Semiconductor Manufacturing 3% |
| 4.42M |
| $267M |
| 1.5% |
| 786K | $262M | 1.5% |
| 2.8M | $249M | 1.4% |
Crinetics Pharmaceuticals Inc | 6.46M | $242M | 1.4% |
Apogee Therapeutics Inc | 1.74M | $231M | 1.3% |
| 1.53M | $230M | 1.3% |
| 6.72M | $223M | 1.3% |
| 557K | $217M | 1.3% |
| 4.73M | $192M | 1.1% |
| 497K | $189M | 1.1% |
| 1.31M | $187M | 1.1% |
| 229K | $174M | 1.0% |
| 1.77M | $171M | 1.0% |
| 6.16M | $152M | 0.9% |
| 4.43M | $148M | 0.9% |
| 1.21M | $144M | 0.8% |
| 1.56M | $142M | 0.8% |
| 517K | $141M | 0.8% |
| 227K | $140M | 0.8% |
| 4.83M | $140M | 0.8% |
| 1.99M | $138M | 0.8% |
| 355K | $134M | 0.8% |
Definium Therapeutics (DFTX)
5.91M → 6.85M shares (+16%)
Praxis Precision Medicines (PRAX)
949K → 959K shares (+1%)
Silicon Motion Technology (SIMO)
510K → 786K shares (+54%)
Crinetics Pharmaceuticals Inc
6.4M → 6.46M shares (+1%)
Credicorp (BAP)
451K → 557K shares (+24%)
Edgewise Therapeutics (EWTX)
4.48M → 4.73M shares (+6%)
Vicor Corporation (VICR)
189K → 497K shares (+162%)
Ultra Clean Holdings, Inc. (UCTT)
1.06M → 1.31M shares (+23%)
Curtiss-Wright (CW)
226K → 229K shares (+2%)
Xometry (XMTR)
1.51M → 1.77M shares (+17%)
Terawulf (WULF)
6.06M → 6.16M shares (+2%)
Nextpower (NXT)
1.04M → 1.21M shares (+16%)
Ceco Environmental (CECO)
640K → 1.56M shares (+144%)
Icici Bank (IBN)
4.26M → 4.83M shares (+13%)
Nlight (LASR)
1.77M → 1.99M shares (+12%)
Onto Innovation (ONTO)
321K → 355K shares (+11%)
Rush Street Interactive, Inc. (RSI)
2.62M → 4.34M shares (+66%)
Dave, Inc. (DAVE)
62K → 332K shares (+432%)
Scholar Rock Holding (SRRK)
1.92M → 2.21M shares (+15%)
PTC Therapeutics, Inc. (PTCT)
1.02M → 1.44M shares (+42%)
Life Time Group Holdings, Inc. (LTH)
648K → 2.86M shares (+342%)
Cardinal Infrastructure Group (CDNL)
661K → 1.21M shares (+83%)
Fomento Economico Mexicano SAB
803K → 877K shares (+9%)
Nu Holdings (NU)
7.29M → 8.31M shares (+14%)
Saia (SAIA)
258K → 262K shares (+2%)
